These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 36289064)

  • 61. Gut microbiota changes associated with
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    Gut Microbes; 2023; 15(1):2223345. PubMed ID: 37318134
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection.
    Nooij S; Vendrik KEW; Zwittink RD; Ducarmon QR; Keller JJ; Kuijper EJ; Terveer EM;
    Genome Med; 2024 Feb; 16(1):37. PubMed ID: 38419010
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
    Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
    Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A case report of improvement on ADHD symptoms after fecal microbiota transplantation with gut microbiome profiling pre- and post-procedure.
    Hooi SL; Dwiyanto J; Rasiti H; Toh KY; Wong RKM; Lee JWJ
    Curr Med Res Opin; 2022 Nov; 38(11):1977-1982. PubMed ID: 36164761
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.
    Cotter JM; Nicholson MR; Kociolek LK
    J Pediatric Infect Dis Soc; 2019 Dec; 8(6):580-584. PubMed ID: 31550348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Associates With Functional Alterations in Circulating microRNAs.
    Monaghan TM; Seekatz AM; Markham NO; Yau TO; Hatziapostolou M; Jilani T; Christodoulou N; Roach B; Birli E; Pomenya O; Louie T; Lacy DB; Kim P; Lee C; Kao D; Polytarchou C
    Gastroenterology; 2021 Jul; 161(1):255-270.e4. PubMed ID: 33844988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital.
    Mironova M; Ehrlich AC; Grinspan A; Protano MA
    J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
    He R; Li P; Wang J; Cui B; Zhang F; Zhao F
    Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
    Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
    Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.
    Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic.
    Kazemian N; Kao D; Pakpour S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809421
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States.
    El Halabi J; Palmer N; Fox K; Kohane I; Farhat MR
    J Gastroenterol; 2022 Jan; 57(1):10-18. PubMed ID: 34495400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma.
    Sabus A; Merrow M; Heiden A; Boster J; Koo J; Franklin ARK
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e897-e899. PubMed ID: 33273413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.
    Aby ES; Vaughn BP; Enns EA; Rajasingham R
    Clin Infect Dis; 2022 Oct; 75(9):1602-1609. PubMed ID: 35275989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent
    Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH
    Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.